Brooks Laboratories [BROOKS] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Brooks Laboratories

NSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Brooks Laboratories wins in 5 metrics, Innova Captab wins in 13 metrics, with 0 ties. Innova Captab appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Brooks Laboratories Innova Captab Better
P/E Ratio (TTM) 270.26 36.47 Innova Captab
Price-to-Book Ratio 3.50 4.94 Brooks Laboratories
Debt-to-Equity Ratio 7.73 35.24 Brooks Laboratories
PEG Ratio -0.61 6.96 Brooks Laboratories
EV/EBITDA 49.02 26.29 Innova Captab
Profit Margin (TTM) 2.25% 9.98% Innova Captab
Operating Margin (TTM) 10.72% 11.68% Innova Captab
EBITDA Margin (TTM) 10.72% 11.68% Innova Captab
Return on Equity -10.16% 13.37% Innova Captab
Return on Assets (TTM) -8.06% 8.12% Innova Captab
Free Cash Flow (TTM) $15.98M $-1.09B Brooks Laboratories
1-Year Return -9.07% 18.49% Innova Captab
Price-to-Sales Ratio (TTM) 4.24 3.64 Innova Captab
Enterprise Value $3.83B $50.14B Innova Captab
EV/Revenue Ratio 4.25 3.85 Innova Captab
Gross Profit Margin (TTM) 37.71% 37.21% Brooks Laboratories
Revenue per Share (TTM) $32 $227 Innova Captab
Earnings per Share (Diluted) $0.47 $22.72 Innova Captab
Beta (Stock Volatility) 0.77 N/A N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Brooks Laboratories vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Brooks Laboratories
Innova Captab
Brooks Laboratories Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Brooks Laboratories-4.69%-3.24%-10.19%-10.16%5.78%-28.73%
Innova Captab-1.16%-0.39%-1.92%-2.66%1.73%-23.68%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Brooks Laboratories-9.07%21.19%114.15%112.06%272.76%272.76%
Innova Captab18.49%56.39%56.39%56.39%56.39%56.39%

News Based Sentiment: Brooks Laboratories vs Innova Captab

Brooks Laboratories

News based Sentiment: NEGATIVE

October was a difficult month for Brooks Laboratories, with a significant divergence between standalone and consolidated profits, coupled with a substantial stock price decline. While standalone results were positive, the overall picture is concerning, making this a significant month for investors to reassess their positions.

View Brooks Laboratories News Sentiment Analysis

Innova Captab

News based Sentiment: POSITIVE

Innova Captab reported positive financial results for both Q1 FY26 and FY2025, and is actively expanding its operations with a new land purchase. While the share price has experienced some recent volatility, analyst sentiment remains largely positive, suggesting a generally favorable outlook for the company.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Brooks Laboratories vs Innova Captab

MetricBROOKSINNOVACAP
Market Information
Market Cap i₹3.86B₹47.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i37,95330,892
90 Day Avg. Volume i41,40135,912
Last Close₹124.81₹836.90
52 Week Range₹95.55 - ₹198.86₹662.00 - ₹1,260.00
% from 52W High-37.24%-33.58%
All-Time High₹198.86 (Jan 06, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-37.24%-33.58%
Growth Metrics
Quarterly Revenue Growth0.42%0.20%
Quarterly Earnings Growth0.42%0.05%
Financial Health
Profit Margin (TTM) i0.02%0.10%
Operating Margin (TTM) i0.11%0.12%
Return on Equity (TTM) i-0.10%0.13%
Debt to Equity (MRQ) i7.7335.24
Cash & Liquidity
Book Value per Share (MRQ)₹36.34₹167.66
Cash per Share (MRQ)₹0.42₹11.41
Operating Cash Flow (TTM) i₹-42,666,000₹282.88M
Levered Free Cash Flow (TTM) i₹-99,670,000₹1.28B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Brooks Laboratories vs Innova Captab

MetricBROOKSINNOVACAP
Price Ratios
P/E Ratio (TTM) i270.2636.47
Forward P/E i21.8619.92
PEG Ratio i-0.616.96
Price to Sales (TTM) i4.243.64
Price to Book (MRQ) i3.504.94
Market Capitalization
Market Capitalization i₹3.86B₹47.41B
Enterprise Value i₹3.83B₹50.14B
Enterprise Value Metrics
Enterprise to Revenue i4.253.85
Enterprise to EBITDA i49.0226.29
Risk & Other Metrics
Beta i0.77N/A
Book Value per Share (MRQ) i₹36.34₹167.66

Financial Statements Comparison: Brooks Laboratories vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BROOKSINNOVACAP
Revenue/Sales i₹255.12M₹3.52B
Cost of Goods Sold i₹158.93M₹2.21B
Gross Profit i₹96.19M₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹27.35M₹410.54M
EBITDA i₹102.78M₹565.82M
Pre-Tax Income i₹95.85M₹426.77M
Income Tax i₹0₹116.62M
Net Income (Profit) i₹95.85M₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BROOKSINNOVACAP
Cash & Equivalents i₹434,000₹155.19M
Total Current Assets i₹338.77M₹7.03B
Total Current Liabilities i₹228.44M₹3.53B
Long-Term Debt i₹13.70M₹2.45B
Total Shareholders Equity i₹981.04M₹9.59B
Retained Earnings i₹-486.52M₹4.53B
Property, Plant & Equipment i₹3.45M₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BROOKSINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBROOKSINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i37,95330,892
Average Daily Volume (90 Day) i41,40135,912
Shares Outstanding i29.46M57.22M
Float Shares i13.55M15.70M
% Held by Insiders i0.56%0.72%
% Held by Institutions i0.10%0.19%

Dividend Analysis & Yield Comparison: Brooks Laboratories vs Innova Captab

MetricBROOKSINNOVACAP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A